Evaluation of Self-Reported Progression and Correlation of Imatinib Dose to Survival in Patients with Metastatic Gastrointestinal Stromal Tumors: An Open Cohort Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.